Evidence map›Paper›PMID 28811794›Full record

ArticlePakistan journal of medical sciences

Comparing the effects of two different contact lenses on corneal re-epithelialization after corneal collagen cross-linking.

Yusuf Kocluk, Savas Cetinkaya, Emine Alyamac Sukgen, Murat Günay, Alper Mete

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04168112 (Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04168112 phase4completednot on this map

Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study

TypeinterventionalSponsorSight Medical Doctors PLLCRan2020 to 2023Enrolled20ConditionsKeratoconus, Unstable, Collagen Crosslinking, Postoperative PainArmsDextenza, Prednisolone Acetate
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yusuf KoclukYusuf Kocluk, MD. Adana Numune Training and Research Hospital, Ophthalmology Clinic, Adana, Turkey.
Savas CetinkayaSavas Cetinkaya, MD. Adana Numune Training and Research Hospital, Ophthalmology Clinic, Adana, Turkey.
Emine Alyamac SukgenEmine Alyamac Sukgen, MD Adana Numune Training and Research Hospital, Ophthalmology Clinic, Adana, Turkey.
Murat GünayMurat Günay, MD. Ophthalmology Clinic, Zeynep Kamil Gynecology and Pediatrics Education and Research Hospital, Istanbul, Turkey.
Alper MeteAlper Mete, MD. Gaziantep University, School of Medicine, Department of Ophthalmology, Gaziantep, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate whether keratoconus (KC) patients who applied the corneal collagen cross-linking (CXL) and two different contact lens (CL) showed any differences in complaints and findings following the CXL.

methodsThis prospective, comparative, double-blind clinical study involved 60 eyes of 60 patients (38 female and 22 male). At the end of the CXL procedure, CL (Balafilcon A) was inserted in 29 patients (Group-1) while CL with different material content (Hioxifilcon A) designed for therapeutic/bandage purposes were inserted in 31 patients (Group-2).

resultsOn the 1

conclusionsWith the use of Balafilcon A and Hioxifilcon A lens materials, KC patients who underwent the CXL were found to have similar symptoms and clinical findings after the CXL. However, epithelial staining and PE were observed more in KC cases accompanied by allergic conjunctivitis.

Indexed as

Allergic conjunctivitisBandage contact lensCorneal collagen cross-linkingCorneal re-epithelializationKeratoconus

Identifiers

PMID28811794
PMCPMC5510126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.